Updated
Updated · Markets Insider · Jul 9
Oh!Nutrition Cites 92% Recovery Gain in 500-User GLP-1 Survey as Muscle-Loss Fears Rise
Updated
Updated · Markets Insider · Jul 9

Oh!Nutrition Cites 92% Recovery Gain in 500-User GLP-1 Survey as Muscle-Loss Fears Rise

3 articles · Updated · Markets Insider · Jul 9

Summary

  • More than 500 Oh!mino users taking GLP-1 drugs reported 88% maintained strength and 92% improved recovery in an Oh!Nutrition survey released Thursday.
  • GLP-1 muscle loss has become a growing concern because lean body mass can make up roughly 25% to 40% of total weight lost during therapy, with a 2025 meta-analysis putting the average at 30.8%.
  • Reduced appetite from GLP-1 medications can make protein and amino acid intake harder, which Oh!Nutrition says its zero-calorie Oh!mino supplement addresses by delivering all nine essential amino acids in one scoop.
  • The company said the findings reflect self-reported customer experience rather than a clinical trial, as incretin-based therapy use has risen 587% over five years, expanding the market for muscle-preservation products.

Insights

As weight-loss drugs cause muscle loss, are supplements a real fix or a new industry profiting from a predictable side effect?
Beyond supplements, what are the most critical diet and exercise strategies for anyone taking these popular new weight-loss medications?
A company survey shows impressive results, but where is the independent clinical data to prove these supplements actually work?